Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 14 Feb 2025

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

in Cancer Molecular Targets and Therapeutics

Jian-Hao Zheng
Ding Shi
Yun-Jie Chen
Jian-Ping Liu
Zheng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1544173

545 views

Original Research

Published on 12 Feb 2025

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

in Cancer Molecular Targets and Therapeutics

Jiaxing Zhang
Gang Wang
Jie Liu
Futian Tang
Song Wang
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1513622

1,168 views

Review

Published on 12 Feb 2025

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

in Cancer Molecular Targets and Therapeutics

Hao Tian
Qin Luo
Liuyang Huang
Guang Chen
Mingsheng Sun
Fanrong Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1527331

896 views

Review

Published on 12 Feb 2025

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

in Cancer Molecular Targets and Therapeutics

Lili Wang
Min Zhang
Kelei Zhao
Xiaohan Yuan
Houyu Zhao
Yanting Liu
Yinghua Ji
Ping Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1451130

774 views

Review

Published on 11 Feb 2025

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance

in Cancer Molecular Targets and Therapeutics

Caihong Li
Dongkai Cheng
Peng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1542811

1,617 views

Review

Published on 11 Feb 2025

New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine

in Cancer Molecular Targets and Therapeutics

Minghui Zhang
Zongao Wang
Shaojun Liu
Yuxuan Li
Yanting Gong
Min Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1488289

557 views

Editorial

Published on 11 Feb 2025

Editorial: Drug repurposing for cancer treatment: current and future directions

in Cancer Molecular Targets and Therapeutics

Marios Lampros
Nikolaos Vlachos
Georgios D. Lianos
Christina Bali
George A. Alexiou

Frontiers in Oncology

doi 10.3389/fonc.2025.1550672

560 views

Case Report

Published on 10 Feb 2025

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Zhihua Li
Jian Chu
Wennan Shen
Junnan Chen
Yuemei Dong
Manze Zhang
Nan Zhao
Wei Zhao
Haoran Zha
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1484383

598 views

Mini Review

Published on 10 Feb 2025

Improving CD3 bispecific antibody therapy in solid tumors using combination strategies

in Cancer Molecular Targets and Therapeutics

Katy Lloyd
Jim Middelburg
Vitalijs Ovcinnikovs
Nora Pencheva
Kristel Kemper
Thorbald van Hall

Frontiers in Oncology

doi 10.3389/fonc.2025.1548446

1,639 views

Review

Published on 07 Feb 2025

Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers

in Cancer Molecular Targets and Therapeutics

Tingting Zhao
Zhe Zhang
Zhuo Chen
Guozheng Xu
Yongxi Wang
Fang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1534948

1,040 views

Review

Published on 07 Feb 2025

Organoid models: applications and research advances in colorectal cancer

in Cancer Molecular Targets and Therapeutics

Yijie Wu
Yu Sha
Xingpo Guo
Ling Gao
Jian Huang
Song-Bai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1432506

913 views

Mini Review

Published on 06 Feb 2025

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities

in Cancer Molecular Targets and Therapeutics

Wen-yu Cai
Xin-xian Cai
Yi-ran Fei
Rui Ye
Ding-ming Song
Dan Hu
Wan-wan Zhang
Ming-fei Xia
Xiao-xiao Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1534055

1,164 views

Original Research

Published on 06 Feb 2025

Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study

in Cancer Molecular Targets and Therapeutics

Toshiaki Tsurui
Kazuyuki Hamada
Emiko Mura
Risako Suzuki
Nana Iriguchi
Tomoyuki Ishiguro
Yuya Hirasawa
Ryotaro Ohkuma
Masahiro Shimokawa
Hirotsugu Ariizumi

Frontiers in Oncology

doi 10.3389/fonc.2025.1499650

701 views

Original Research

Published on 06 Feb 2025

A pan-cancer analysis of homeobox family: expression characteristics and latent significance in prognosis and immune microenvironment

in Cancer Molecular Targets and Therapeutics

Yuanhui Wang
Jie Gao
Ziyi Ren
Ziyi Shen
Wei Gu
Qinyi Miao
Xiaomeng Hu
Yan Wu
Wei Liu
Jia Jia

Frontiers in Oncology

doi 10.3389/fonc.2025.1521652

704 views

Systematic Review

Published on 04 Feb 2025

Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook

in Cancer Molecular Targets and Therapeutics

Bassam Abdul Rasool Hassan
Ali Haider Mohammed
Souheil Hallit
Diana Malaeb
Hassan Hosseini

Frontiers in Oncology

doi 10.3389/fonc.2025.1475893

1,504 views

Review

Published on 03 Feb 2025

MicroRNA155 in non-small cell lung cancer: a potential therapeutic target

in Cancer Molecular Targets and Therapeutics

Xiangju Wei
Xianmin Xiong
Ze Chen
Bi Chen
Cantang Zhang
Wenhui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1517995

822 views